美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=BRIVARACETAM"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
BRIVARACETAM 214875 004 ANDA BRIVARACETAM TABLET;ORAL 75MG No No 2023/11/06 (TA) -- APOTEX INC None (Tentative Approval)
BRIVARACETAM 214875 005 ANDA BRIVARACETAM TABLET;ORAL 100MG No No 2023/11/06 (TA) -- APOTEX INC None (Tentative Approval)
BRIVARACETAM 214921 002 ANDA BRIVARACETAM TABLET;ORAL 25MG No No 2023/11/09 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
BRIVARACETAM 214921 003 ANDA BRIVARACETAM TABLET;ORAL 50MG No No 2023/11/09 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
BRIVARACETAM 214921 004 ANDA BRIVARACETAM TABLET;ORAL 75MG No No 2023/11/09 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
BRIVARACETAM 214921 005 ANDA BRIVARACETAM TABLET;ORAL 100MG No No 2023/11/09 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
BRIVARACETAM 214922 001 ANDA BRIVARACETAM SOLUTION; ORAL 10MG/ML No No 2023/11/09 (TA) -- MSN LABS PVT LTD None (Tentative Approval)
BRIVARACETAM 214924 001 ANDA BRIVARACETAM SOLUTION;INTRAVENOUS 50MG/5ML (10MG/ML) No No 2023/11/09 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
BRIVARACETAM 214831 002 ANDA BRIVARACETAM TABLET; ORAL 25mg No No 2024/05/24 (TA) -- ANNORA PHARMA None (Tentative Approval)
BRIVARACETAM 214831 003 ANDA BRIVARACETAM TABLET; ORAL 50mg No No 2024/05/24 (TA) -- ANNORA PHARMA None (Tentative Approval)
BRIVARACETAM 214831 004 ANDA BRIVARACETAM TABLET; ORAL 75mg No No 2024/05/24 (TA) -- ANNORA PHARMA None (Tentative Approval)
BRIVARACETAM 214831 005 ANDA BRIVARACETAM TABLET; ORAL 100mg No No 2024/05/24 (TA) -- ANNORA PHARMA None (Tentative Approval)
BRIVARACETAM 218494 001 ANDA BRIVARACETAM SOLUTION;ORAL 10MG/ML No No 2024/08/12 (TA) -- HAINAN POLY PHARM None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database